Management patterns of non-ST segment elevation acute coronary syndromes in relation to prior coronary

Esam Elbarasi1, Shaun G Goodman, Raymond T Yan

  • 1Terrence Donnelly Heart Center, Division of Cardiology, St Michael's Hospital, University of Toronto, and Canadian Heart Research Centre, Toronto, Ontario, Canada.

American Heart Journal
|January 28, 2010
PubMed

Insights

Patients with prior percutaneous coronary intervention (PCI) for non-ST elevation acute coronary syndrome (NSTE-ACS) received more invasive treatment. Those with prior coronary artery bypass graft surgery (CABG) received less invasive therapy, highlighting a management discrepancy.

Area of Science:

  • Cardiology
  • Interventional Cardiology
  • Acute Coronary Syndromes

Background:

  • Contemporary guidelines recommend early invasive strategies for non-ST elevation acute coronary syndrome (NSTE-ACS) patients with prior revascularization.
  • Real-world management patterns for these patients remain under-investigated.

Purpose of the Study:

  • To analyze the management patterns of NSTE-ACS patients with prior coronary revascularization.
  • To compare clinical characteristics and in-hospital procedures based on revascularization history.

Main Methods:

  • Analysis of 3 Canadian registries (ACS I, ACS II, GRACE/expanded-GRACE) including 12,483 NSTE-ACS patients (June 1999 - December 2007).
  • Stratification into four groups: no prior revascularization, prior percutaneous coronary intervention (PCI) only, prior coronary artery bypass graft surgery (CABG) only, and both PCI and CABG.
  • Comparison of clinical characteristics, medication use, and cardiac procedures.

Main Results:

  • Patients with prior PCI and/or CABG were more likely male, with diabetes, myocardial infarction, and heart failure.
  • Prior PCI was independently associated with increased in-hospital cardiac catheterization (aOR 1.18).
  • Prior CABG was independently associated with decreased invasive therapy (aOR 0.77).

Conclusions:

  • NSTE-ACS patients with prior PCI were more likely to undergo invasive treatment.
  • NSTE-ACS patients with prior CABG received less invasive therapy.
  • Further research is needed to assess the appropriateness of this observed treatment discrepancy.
Abstract

Related Concept Videos

Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations01:19

Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations

The pathophysiology of Acute Coronary Syndrome [ACD] involves several key processes:The main underlying cause of ACD is atherosclerosis, a chronic inflammatory disease characterized by the buildup of lipid-laden plaques within the coronary arteries.As the atherosclerotic plaque grows in the coronary artery, it may become unstable due to the formation of a lipid-rich core and a thin fibrous cap. Inflammatory cells within the plaque, such as macrophages, secrete enzymes that degrade the...
Acute Coronary Syndrome I: Introduction01:30

Acute Coronary Syndrome I: Introduction

Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
Angina IV: Management01:26

Angina IV: Management

IntroductionThe management of angina requires a comprehensive approach that includes pharmacological therapies, medical procedures, and lifestyle modifications.Pharmacological TherapiesAntiplatelet agents, such as aspirin, clopidogrel, prasugrel, and ticagrelor, play a pivotal role in preventing thrombus formation in patients with angina. These medications inhibit platelet aggregation and reduce the likelihood of myocardial infarction and other cardiovascular events.Anticoagulants, including...
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...